1-32247626-G-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_032648.3(FAM167B):​c.205G>T​(p.Asp69Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

FAM167B
NM_032648.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.682
Variant links:
Genes affected
FAM167B (HGNC:28133): (family with sequence similarity 167 member B)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.05875519).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAM167BNM_032648.3 linkc.205G>T p.Asp69Tyr missense_variant Exon 1 of 2 ENST00000373582.4 NP_116037.2 Q9BTA0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAM167BENST00000373582.4 linkc.205G>T p.Asp69Tyr missense_variant Exon 1 of 2 1 NM_032648.3 ENSP00000362684.3 Q9BTA0

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 27, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.205G>T (p.D69Y) alteration is located in exon 1 (coding exon 1) of the FAM167B gene. This alteration results from a G to T substitution at nucleotide position 205, causing the aspartic acid (D) at amino acid position 69 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
15
DANN
Benign
0.88
DEOGEN2
Benign
0.025
T
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.33
N
LIST_S2
Benign
0.33
T
M_CAP
Benign
0.046
D
MetaRNN
Benign
0.059
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.0
N
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.048
Sift
Benign
0.032
D
Sift4G
Uncertain
0.036
D
Polyphen
0.031
B
Vest4
0.15
MutPred
0.27
Loss of disorder (P = 0.0097);
MVP
0.14
MPC
0.54
ClinPred
0.14
T
GERP RS
2.4
Varity_R
0.10
gMVP
0.21

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-32713227; API